PubRank

Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 27107657)

Published in Leuk Res on April 11, 2016

Authors

Jean E Goasguen1, John M Bennett2, Barbara J Bain3, Richard D Brunning4, Maria-Teresa Vallespí5, Masao Tomonaga6, Gina Zini7, Alain Renault8, International Working Group on Morphology of MDS IWGM-MDS

Author Affiliations

1: University of Rennes, France. Electronic address: Jean.goasguen@orange.fr.
2: University of Rochester, NY, USA.
3: Imperial College, London, UK.
4: University of Minnesota, USA.
5: Vall d'Hebrón Hospital, Barcelona, Spain.
6: University of Nagasaki, Japan.
7: Haematology Institute, Catholic University of Sacred Heart, Rome, Italy.
8: University of Rennes and INSERM CIC1414, France.

Articles citing this ↘

Diagnostics and Prognostication of Myelodysplastic Syndromes. Ann Lab Med (2017) 0.75

Articles by these authors ⇆

Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res (2013) 1.42

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance. Ann Hematol (2017) 0.75